Infectious Diseases (except HIV/AIDS)

  1. Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study

    1. S Reshwan K Malahe
    2. Rogier A S Hoek
    3. Virgil A S H Dalm
    4. Annoek E C Broers
    5. Caroline M den Hoed
    6. Olivier C Manintveld
    7. Carla C Baan
    8. Charlotte M van Deuzen
    9. Grigorios Papageorgiou
    10. Hannelore I Bax
    11. Jeroen J Van Kampen
    12. Merel E Hellemons
    13. Marcia M L Kho
    14. Rory D de Vries
    15. Richard Molenkamp
    16. Marlies E J Reinders
    17. Bart J A Rijnders

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities

    1. Peter D. Smits
    2. Samuel Gratzl
    3. Michael Simonov
    4. Senthil K. Nachimuthu
    5. Brianna M. Goodwin Cartwright
    6. Michael D. Wang
    7. Charlotte Baker
    8. Patricia Rodriguez
    9. Mackenzie Bogiages
    10. Benjamin M. Althouse
    11. Nicholas L. Stucky

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Clinical evaluation of an automated, rapid mariPOC antigen test in screening of symptomatics and asymptomatics for SARS‐CoV‐2 infection

    1. Marianne Gunell
    2. Kaisa Rantasärkkä
    3. Rita Arjonen
    4. Antti Sandén
    5. Tytti Vuorinen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Hospitalized Patients With Severe Coronavirus Disease 2019 During the Omicron Wave in Israel: Benefits of a Fourth Vaccine Dose

    1. Tal Brosh-Nissimov
    2. Khetam Hussein
    3. Yonit Wiener-Well
    4. Efrat Orenbuch-Harroch
    5. Meital Elbaz
    6. Shelly Lipman-Arens
    7. Yasmin Maor
    8. Yael Yagel
    9. Bibiana Chazan
    10. Mirit Hershman-Sarafov
    11. Galia Rahav
    12. Oren Zimhony
    13. Adi Zaidman Shimshovitz
    14. Michal Chowers

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Safety, tolerability and immunogenicity of Biological E’s CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study

    1. Subhash Thuluva
    2. Vikram Paradkar
    3. SubbaReddy Gunneri
    4. Vijay Yerroju
    5. Rammohan Reddy Mogulla
    6. Pothakamuri Venkata Suneetha
    7. Kishore Turaga
    8. Mahesh Kyasani
    9. Senthil Kumar Manoharan
    10. Srikanth Adabala
    11. Aditya Sri Javvadi
    12. Guruprasad Medigeshi
    13. Janmejay Singh
    14. Heena Shaman
    15. Akshay Binayke
    16. Aymaan Zaheer
    17. Amit Awasthi
    18. Manish Narang
    19. Pradeep Nanjappa
    20. Niranjana Mahantshetti
    21. Bishan Swarup Garg
    22. Anil Kumar Pandey

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Anti SARS-CoV-2 seroprevalence in Zanzibar in 2021 before the Omicron wave

    1. Salum Seif Salum
    2. Mohammed Ali Sheikh
    3. Antje Hebestreit
    4. Sørge Kelm

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Ribavirin antiviral combination therapy in COVID 19, a single-center experience

    1. Budha O Singh
    2. Gaurav Chikara
    3. Prasan Kumar Panda
    4. Yogesh Arvind Bahurupi
    5. Sarama Saha
    6. Venkatesh S. Pai

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Antibody response and intra‐host viral evolution after plasma therapy in COVID ‐19 patients pre‐exposed or not to B‐cell‐depleting agents

    1. David Gachoud
    2. Trestan Pillonel
    3. Gerasimos Tsilimidos
    4. Dunia Battolla
    5. Dominique Dumas
    6. Onya Opota
    7. Stefano Fontana
    8. Peter Vollenweider
    9. Oriol Manuel
    10. Gilbert Greub
    11. Claire Bertelli
    12. Nathalie Rufer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants

    1. Thandeka Moyo-Gwete
    2. Mashudu Madzivhandila
    3. Nonhlanhla N. Mkhize
    4. Prudence Kgagudi
    5. Frances Ayres
    6. Bronwen E. Lambson
    7. Nelia P. Manamela
    8. Simone I. Richardson
    9. Zanele Makhado
    10. Mieke A. van der Mescht
    11. Zelda de Beer
    12. Talita Roma de Villiers
    13. Wendy A. Burgers
    14. Ntobeko A. B. Ntusi
    15. Theresa Rossouw
    16. Veronica Ueckermann
    17. Michael T. Boswell
    18. Penny L. Moore

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS)

    1. Malathi Murugesan
    2. Padmanaban Venkatesan
    3. Senthil Kumar
    4. Premkumar Thangavelu
    5. Winsley Rose
    6. Jacob John
    7. Marx Castro
    8. T. Manivannan
    9. Venkata Raghava Mohan
    10. Priscilla Rupali

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 167 of 716 Next